Towards developing a variant-proof SARS-CoV-2 vaccine.
作者信息
Peng Hua, Fu Yang-Xin
机构信息
Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing, China.
出版信息
Cell Res. 2023 Jan;33(1):5-6. doi: 10.1038/s41422-022-00753-4.
PMID:36588119
Abstract
摘要
相似文献
引用本文的文献
本文引用的文献
[1]
Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein.
Proc Natl Acad Sci U S A. 2022-10-4
[2]
[3]
SARS-CoV-2 S2-targeted vaccination elicits broadly neutralizing antibodies.
Sci Transl Med. 2022-7-27
[4]
[5]
[6]
Structural conservation among variants of the SARS-CoV-2 spike postfusion bundle.
Proc Natl Acad Sci U S A. 2022-4-19
[7]
[8]
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans.
Science. 2020-11-6
[9]
Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein.
Nat Commun. 2020-7-17
Zotero 插件